Trial
NCT02888756
iHIVARNA Clinical Trial in HIV Infected Individuals
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Rob Gruters
Collaborators
Institut d'Investigacions Biomèdiques August Pi i Sunyer; IrsiCaixa; Institute of Tropical Medicine, Belgium; Vrije Universiteit Brussel; Synapse bv; Asphalion; eTheRNA immunotherapies; CR2O; Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Universitair Ziekenhuis Brussel
Condition
HIV Infections
Intervention
iHIVARNA-01
Why stopped
Interim analysis did not show sufficient immunogenicity of IMP compared to placebo
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-23